Literature DB >> 15763615

The vagina as a route for systemic drug delivery.

Alamdar Hussain1, Fakhrul Ahsan.   

Abstract

Exhaustive efforts have been made toward the administration of drugs, via alternative routes, that are poorly absorbed after the oral administration. The vagina as a route of drug delivery has been known since ancient times. In recent years, the vaginal route has been rediscovered as a potential route for systemic delivery of peptides and other therapeutically important macromolecules. However, successful delivery of drugs through the vagina remains a challenge, primarily due to the poor absorption across the vaginal epithelium. The rate and extent of drug absorption after intravaginal administration may vary depending on formulation factors, vaginal physiology, age of the patient and menstrual cycle. Suppositories, creams, gels, tablets and vaginal rings are commonly used vaginal drug delivery systems. The purpose of this communication is to provide the reader with a summary of advances made in the field of vaginal drug delivery. This report, therefore, summarizes various vaginal drug delivery systems with an introduction to vaginal physiology and factors affecting drug absorption from the vaginal route.

Entities:  

Mesh:

Year:  2005        PMID: 15763615     DOI: 10.1016/j.jconrel.2004.11.034

Source DB:  PubMed          Journal:  J Control Release        ISSN: 0168-3659            Impact factor:   9.776


  73 in total

1.  Non-Antiretroviral Microbicides for HIV Prevention.

Authors:  Yanille Scott; Charlene S Dezzutti
Journal:  AIDS Rev       Date:  2016 Jul-Sep       Impact factor: 2.500

2.  Rapid transport of large polymeric nanoparticles in fresh undiluted human mucus.

Authors:  Samuel K Lai; D Elizabeth O'Hanlon; Suzanne Harrold; Stan T Man; Ying-Ying Wang; Richard Cone; Justin Hanes
Journal:  Proc Natl Acad Sci U S A       Date:  2007-01-23       Impact factor: 11.205

3.  Cervical cancer treatment with a locally insertable controlled release delivery system.

Authors:  Vandana Keskar; Prem S Mohanty; Ernest J Gemeinhart; Richard A Gemeinhart
Journal:  J Control Release       Date:  2006-08-26       Impact factor: 9.776

Review 4.  Vaginal drug distribution modeling.

Authors:  David F Katz; Andrew Yuan; Yajing Gao
Journal:  Adv Drug Deliv Rev       Date:  2015-04-28       Impact factor: 15.470

Review 5.  Biomaterials and Contraception: Promises and Pitfalls.

Authors:  Isabella Claure; Deborah Anderson; Catherine M Klapperich; Wendy Kuohung; Joyce Y Wong
Journal:  Ann Biomed Eng       Date:  2019-11-07       Impact factor: 3.934

6.  Investigation of the physicochemical and physicomechanical properties of a novel intravaginal bioadhesive polymeric device in the pig model.

Authors:  Valence M K Ndesendo; Viness Pillay; Yahya E Choonara; Lisa C du Toit; Eckhart Buchmann; Leith C R Meyer; Riaz A Khan; Uwe Rosin
Journal:  AAPS PharmSciTech       Date:  2010-05-06       Impact factor: 3.246

Review 7.  Enhancing the buccal mucosal delivery of peptide and protein therapeutics.

Authors:  Thiago Caon; Liang Jin; Cláudia M O Simões; Raymond S Norton; Joseph A Nicolazzo
Journal:  Pharm Res       Date:  2014-08-29       Impact factor: 4.200

8.  Accidental death via intravaginal absorption of methamphetamine.

Authors:  Prentiss Jones; Romeo Mutsvunguma; Joseph A Prahlow
Journal:  Forensic Sci Med Pathol       Date:  2014-02-11       Impact factor: 2.007

9.  Exposure to Volatile Organic Compounds and Use of Feminine Hygiene Products Among Reproductive-Aged Women in the United States.

Authors:  Ning Ding; Stuart Batterman; Sung Kyun Park
Journal:  J Womens Health (Larchmt)       Date:  2019-09-18       Impact factor: 2.681

10.  General tissue characteristics of the lower urethral and vaginal walls in the domestic rabbit.

Authors:  Jorge Rodríguez-Antolín; Nicté Xelhuantzi; Mario García-Lorenzana; Estela Cuevas; Robyn Hudson; Margarita Martínez-Gómez
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2008-09-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.